Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;33(2):107-11.
doi: 10.4103/0971-5851.99746.

Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma

Affiliations

Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma

Debdas Bose et al. Indian J Med Paediatr Oncol. 2012 Apr.

Abstract

Context: The diagnosis of papillary thyroid carcinoma (PTC) is based on nuclear features. These features may be present in focal areas in benign thyroid diseases and follicular adenoma (FA), leading to diagnostic difficulty.

Aims: To evaluate the expression and pattern of the distribution of cytokeratin 19 (CK19) in PTC and compare its reactivity with other neoplastic and non-neoplastic conditions to assess its potential as a useful marker for PTC.

Materials and methods: Twenty two cases of papillary carcinoma (usual type, follicular and diffuse sclerosing variant), eight follicular adenomas, eight multinodular goiters (MNG) were collected for a period of two years and six months. Sections were taken from thyroidectomy specimens fixed in 10% buffered neutral formalin. Hematoxylin and eosin staining and immunohistochemical staining for CK19 were done using standard protocol. Results were semiquantitatively scored as follows: 1+ (<5% positively stained cells), 2+ (5-25%), 3+ (25-75%) and 4+ (>75%), and then analyzed.

Statistical analysis and results: All 22 (100%) papillary carcinomas showed diffuse and strong (3+ and 4+) CK19 expression. Six out of eight (75%) FAs and four out of eight (50%) MNG were positive for CK19, but it was of weaker intensity (1+ and 2+) and focal in distribution.

Conclusion: Focal CK19 staining may be found in benign disease, but diffuse and strong positivity is characteristic of PTC, which can be used in the diagnosis of PTC in lesions of equivocal morphological appearances.

Keywords: Cytokeratin 19; follicular adenoma; multinodular goitre; papillary thyroid carcinoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
(a) A usual type papillary thyroid carcinoma (hematoxylineosin, ×LP), (b) A usual type papillary thyroid carcinoma, immunostaining for cytokeratin 19-diffuse and strong (4+) positive (IHC, ×LP, inset HP)
Figure 2
Figure 2
(a) A follicular variant papillary thyroid carcinoma with typical nuclear features (hematoxylin-eosin, ×HP) (b) A follicular variant papillary thyroid carcinoma, immunostaining for cytokeratin 19 (IHC, ×HP)
Figure 3
Figure 3
(a) Photomicrograph of a follicular adenoma (hematoxylineosin, ×LP) (b) A follicular adenoma, immunostaining for cytokeratin 19, focal positive (1+) (IHC, ×LP)
Figure 4
Figure 4
(a) Photomicrograph of multinodular goiter (hematoxylineosin, ×LP) (b) A multinodular goiter, negative immunostaining for cytokeratin 19 (IHC, ×LP)

References

    1. DeLellis RA, Lloyd RV, Heitz PU, Eng C. World Health Organization Classification of Tumours. Lyon: IARC Press; 2004. Pathology and genetics of tumors of endocrine organs; pp. 57–66.
    1. Chan JK. Papillary thyroid carcinoma: Classical and variants. Histol Histopathology. 1990;5:241–57. - PubMed
    1. Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Clev Clin Q. 1976;97:207–16. - PubMed
    1. Chan JK. Thyroid and parathyroid. In: Weidner N, Cote RJ, Suster S, Weiss ML, editors. Modern Surgical Pathology. 2nd Ed. Philadelphia: Saunders; 2003. pp. 1661–754.
    1. Miettinen M, Kovatich AJ, Karkkainen P. Keratin subsets in papillary and follicular thyroid lesions: A paraffin section analysis with diagnostic implications. Virchows Arch. 1997;431:407–13. - PubMed